Aptevo Therapeutics (APVO) Research & Development (2015 - 2026)
Aptevo Therapeutics' Research & Development was $3.7 million in Q2 2026, up 11.1% from $3.33 million a year earlier but down 5.8% from the prior quarter.
Powered by 
Analysis
Aptevo Therapeutics (APVO) Research & Development (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Aptevo Therapeutics' Research & Development was $15.2 million through Jun 30, 2026, up 9.0% year-over-year; for FY2025, it came in at $14.54 million, up 1.1% from FY2024.
- Research & Development shows a five-year compound annual growth rate of -4.0% (FY2020 to FY2025).
- In earlier years, Research & Development was $14.38 million in FY2024 (-16.0%), $17.11 million in FY2023 (-4.3%), $17.88 million in FY2022 (-5.9%) and $18.99 million in FY2021 (+6.4%).
- Quarterly Research & Development has moved between $3.1 million (Q3 2024) and $5.46 million (Q2 2023) over five years.
- Compared with a year earlier, Research & Development was higher in four of the last eight quarters, with growth averaging 2.1%.
- The best year-over-year quarter for Research & Development over five years was Q2 2023 (growth of 41.3%); the worst was Q2 2024 (a decline of 33.3%).
- Per Business Quant data, APVO's Research & Development in the three quarters before Q2 2026 was $3.92 million (Q1 2026), $3.54 million (Q4 2025) and $4.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Aptevo Therapeutics | 2.71 Mn | -64.29 Mn | - | 3.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.70 Mn |
| Mar 31, 2026 | 3.92 Mn |
| Dec 31, 2025 | 3.54 Mn |
| Sep 30, 2025 | 4.04 Mn |
| Jun 30, 2025 | 3.33 Mn |
| Mar 31, 2025 | 3.63 Mn |
| Dec 31, 2024 | 3.88 Mn |
| Sep 30, 2024 | 3.10 Mn |
| Jun 30, 2024 | 3.64 Mn |
| Mar 31, 2024 | 3.75 Mn |
| Dec 31, 2023 | 3.59 Mn |
| Sep 30, 2023 | 3.89 Mn |
| Jun 30, 2023 | 5.46 Mn |
| Mar 31, 2023 | 4.17 Mn |
| Dec 31, 2022 | 4.67 Mn |
| Sep 30, 2022 | 4.48 Mn |
| Jun 30, 2022 | 3.87 Mn |
| Mar 31, 2022 | 4.87 Mn |
| Dec 31, 2021 | 4.54 Mn |
| Sep 30, 2021 | 4.37 Mn |
API Access
Aptevo Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();